Webinar | Nestlé and Arla are leading GLP-1 food innovation. Is your R&D keeping up?​ Register Now

Arisaph Pharmaceuticals

Arisaph Pharmaceuticals is focused on the development of therapies for cancer, cardiovascular disease, and diabetes.
1999
11-50
Boston, Massachusetts, United States
  • Diabetes (Glucose Monitoring)
  • Drug Discovery and Development
  • Oncology (Cancer)
  • Pharmaceuticals

Investment Funding

Last Funding Stage

Venture - Series Unknown

Total Funding Amount

10.M

Last Funding Amount

10.M

Last Funding Date

01-11-2013

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information